Mavacamten by Bristol-Myers Squibb is a new breath for all patients with obstructive hypertrophic cardiomyopathy.
Metabolism
Posted inMetabolism, New Drugs, Regulatory
Twymeeg: Completely New Drug for Treatment of Type 2 Diabetes Mellitus
Imeglimin is a universal anti-diabetic drug that incorporates the power of all existing glucose-lowering drugs.
Posted inMetabolism, New Drugs, Regulatory
Kerendia: New Drug for Diabetic Kidney Disease
Finerenone for the treatment of diabetic nephropathy, a chronic kidney disease associated with type 2 diabetes mellitus.
Posted inClinical Trials, Metabolism, Neuroscience, Rare/Orphan Diseases
Redasemtide: Universal Medicine for Regeneration of Any Tissue
Redasemtide as a lifesaver for the most devastating diseases, including stroke, osteoarthritis, cardiomyopathy, and bullous epidermolysis.
Posted inMetabolism, New Drugs, Rare/Orphan Diseases, Regulatory
Leqvio: Newest Drug Against ‘Very Bad’ Cholesterol
Two injections of inclisiran a year and you can forget about high cholesterol. Novartis doesn’t lie.
Posted inClinical Trials, Metabolism
Innovative Treatment for Hypertension: One Shot Every Quarter or Even Six Months
Arterial hypertension is waiting for a major pharmacological breakthrough. Hundreds of millions of people will be saved.
Posted inClinical Trials, Metabolism
Wegovy: Impressive Success of Semaglutide for Weight Loss
Novo Nordisk’s newest drug did well in treating obesity and overweight.
